Mucosal immunization application to allergic disease: Sublingual immunotherapy

Allergy and Asthma Proceedings

Volumn 28, Issue 1, 2007, Pages 35-39

  Frati, Franco ^a,b,c   Moingeon, Philippe ^a,d   Marcucci, Francesco ^a,b   Puccinelli, Paola ^a,c   Sensi, Laura ^a,b   Di Cara, Giuseppe ^a,b   Incorvaia, Cristoforo ^a,b  

^a University of Perugia ^*

^b Medical and Scientific Department   (Italy)

^c Istituti Clinici di Perfezionamento   (France)

^d Rheumatology   (Italy)

Author keywords

Allergic disease; Mucosal immunization; Oral mucosa; Sublingual immunotherapy; Tolerance

Indexed keywords

ALLERGEN;

DENDRITIC CELL; DESENSITIZATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUTH MUCOSA; MUCOSAL IMMUNITY; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT ALLERGY; REVIEW; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; MOUTH MUCOSA; RESPIRATORY HYPERSENSITIVITY; T-LYMPHOCYTES, REGULATORY;

EID: 33847612479     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2007.28.2919     Document Type: Review

References (36)

1. Bousquet J, Lockey R, and Malling HJ (Eds). WHO position paper. Allergen immunotherapy: Therapeutical vaccines for allergic diseases. Ann Allergy Asthma Immunol 81:401-405, 1998.
2. Scadding GK, and Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 16:483-491, 1986.
3. Canonica GW, and Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 111:437-448, 2003.
4. Wilson DR, Torres-Lima M, and Durham S. Sublingual immunotherapy for allergic rhinitis: Systematic review and meta-analysis. Allergy 60:4-12, 2005.
5. André C, Vatrinet C, Galvain S, et al. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 121:229-234, 2000.
6. Gidaro G, Marcucci F, Sensi L, et al. The safety of sublingual-swallow immunotherapy: An analysis of published studies. Clin Exp Allergy 35:565-571, 2005.
7. Tari MG, Mancino M, and Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol 18:277-284, 1990.
8. Marcucci F, Sensi L, Di Cara G, et al. Dose dependence of immunological response to sublingual immunotherapy. Allergy 60:952-956, 2005.
9. Litwin A, Flanagan M, Entis G, et al. Oral immunotherapy with short ragweed extract in a novel encapsuled preparation: A double-blind study. J Allergy Clin Immunol 100:30-38, 1997.
10. van Loon LA, Krieg SR, Davidson CL, et al. Quantification and distribution of lymphocyte subsets and Langerhans cells in normal human oral mucosa and skin. J Oral Pathol Med 18:197-201, 1989.
11. Allam JP, Novak N, Fuchs C, et al. Characterization of dendritic cells from human oral mucosa: A new Langerhans cell type with high constitutive Fcepsilon RI expression. J Allergy Clin Immunol 112:141-148, 2003.
12. von Bubnoff D, Fimmers R, Bogdanov M, et al. Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin 10 production during seasonal allergen exposure. Clin Exp Allergy 34:1056-1063, 2004.
13. Umetsu DT, Akbari O, and DeKruyff RH. Regulatory T cells control the development of allergic disease and asthma. J Allergy Clin Immunol 112:480-487, 2003.
14. Blaser K, and Akdis C. Interleukin 10, T regulatory cells, and specific allergy treatment. Clin Exp Allergy 34:328-331, 2004.
15. Wakkach A, Fournier N, Brun V, et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18:605-617, 2003.
16. Yamagiwa S, Gray JD, Hashimoto S, et al. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheralblood. J Immunol 166:7282-7289, 2001.
17. Gambineri E, Torgerson T, and Ochs H. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of Foxp3, a critical regulator of T cell homeostasis. Curr Opin Rheumatol 15:430-435, 2003.
18. Ling EM, Smith T, Nguyen XD, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363:608-615, 2004.
19. Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T Helper 2 cells. J Exp Med 199:1567-1575, 2004.
20. Akdis C, Blaser K, and Akdis M. Genes of tolerance. Allergy 59:897-913, 2004.
21. Marcucci F, Sensi L, Frati F, et al. Sublingual tryptase and ECP in children treated with grass-pollen sublingual immunotherapy (SLIT): Safety and immunological implications. Allergy 56:1091-1095, 2001.
22. Walsh LJ. Mast cells and oral inflammation. Crit Rev Oral Biol Med 14:188-198, 2003.
23. Bagnasco M, Mariani G, Passalacqua G, et al. Absorption and distribution kinetics of the major Parietaria allergen adminis tered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 100:121-129, 1997.
24. Bagnasco M, Passalacqua G, Villa G, et al. Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers. Clin Exp Allergy 31:54-60, 2001.
25. Passalacqua G, Altrinetti V, Mariani G, et al. Pharmacokinetics of radiolabelled Pa j 1 administered intranasally to allergic and healthy subjects. Clin Exp Allergy 35:880-883, 2005.
26. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 18:787-811, 2000.
27. Noirey N, Rougier N, André C, et al. Langerhans-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naive T lymphocytes. J Allergy Clin Immunol 105:1194-1201, 2000.
28. Bousquet J. Sublingual immunotherapy: From proven prevention to putative rapid relief of allergic symptoms. Allergy 60:1-3, 2005.
29. Bowen T, Greenbaum J, Charbonneau Y, et al. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis. Ann Allergy Asthma Immunol 93:425-430, 2004.
30. Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect sublingual immunotherapy in children with asthma due to house dust mite: A 10-year prospective study. Clin Exp Allergy 33:206-210, 2003.
31. Groux H, Fournier N, and Cottrez F. Role of dendritic cells in the generation of regulatory T cells. Semin Immunol 16:99-106, 2004.
32. Samson JN. Regulation of antigen-specific regulatory T-cell induction via nasal and oral mucosa. Crit Rev Immunol 24:157-177, 2004.
33. Battaglia M, Gianfrani C, Gregori S, et al. IL-10 producing T regulatory type 1 cells and oral tolerance. Am N Y Acad Sci 1029:142-153, 2004.
34. Ciprandi G, Fenoglio D, Cirillo I, et al. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: A preliminary report. Ann Allergy Asthma Immunol 95:38-44, 2005.
35. Marcucci F, Sensi L, Di Cara G, et al. Sublingual reactivity to rBet v 1 and Phi p 1 in patients with oral allergy sindrome. Int J Immunopathol Pharmacol. In press.
36. Pajno GB, Vita D, Caminiti L, et al. Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol 116:1380-1381, 2005.